Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease

Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease

US Patent 8956611 · Granted Feb 17, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

IBAT inhibitors for the treatment of liver diseases2025
Methods of purifying and producing an adalimumab antibody2024
Therapeutic editing2023
IBAT inhibitors for the treatment of liver diseases2023
Methods for modulating protein mannosylation profiles using maduramycin, narasin2023
IBAT inhibitors for the treatment of liver diseases2022
Cell culture methods for increased cell viability2022
Methods for increasing biosimilarity2021
Methods for modulating protein galactosylation profiles of recombinant proteins 2021
IBAT inhibitors for the treatment of liver diseases2021
Methods for modulating production profiles of recombinant proteins2020
Methods for modulating production profiles of recombinant proteins2020